Risk of Revision Following Knee Arthroplasty in Bariatric Surgery Patients
Risk of Revision and Other Complications Following Knee Arthroplasty in Patients Previously Exposed to Bariatric Surgeries: A Nationwide, Register-based Study
1 other identifier
observational
99,965
1 country
1
Brief Summary
Previous studies have investigated the outcomes of Knee Arthroplasty (KA) following Bariatric Surgery (BAS), but with substantial limitations as not stratifying for Body Mass Index (BMI) at time of KA or not addressing the type of BAS (gastric bypass, banding or sleeve). Since BMI varies greatly in patients with previous BAS, it is likely that BMI affects outcomes after KA in BAS-operated patients. The investigators believe that stratifying for BMI would explain the contradictions with the previous research in this patient group when it comes to the risk of revision after KA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFebruary 27, 2026
February 1, 2026
6 months
September 7, 2023
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hazard rate of Revision due to any cause
Revision surgery is defined as surgery with debridement and/or exchange of at least one component
within 90 days and within 2 years
Hazard rate of Revision due to infection
Our definition of infection is adapted from the European Bone and Joint Infection Society (EBJIS) criteria as at least one of the following A. An indication of deep infection is reported to the Danish knee arthroplasty register (DKR) by the surgeon on revision surgery B. At least 2 deep-tissue samples of phenotypically indistinguishable bacteria isolated from at least 3 deep-tissue samples C. One or more positive intraoperative samples from a closed fluid aspirate AND a biopsy (fluid AND tissue) of phenotypically indistinguishable bacteria isolated.
within 90 days and within 2 years
Secondary Outcomes (3)
Hazard rate of Knee related antibiotic use within 30- and 90-days following KA
within 30- and 90-days following KA
Hazard rate of Antibiotic use due to other causes
within 30- and 90-days following KA
Mortality
2 years postoperatively
Study Arms (2)
BAS group
Patients who received bariatric surgery prior to their knee arthroplasty
Non-BAS group
Patients who did not receive bariatric surgery prior to their knee arthroplasty
Interventions
Eligibility Criteria
The investigators will include patients with primary/idiopathic or secondary (due to meniscus or cruciate ligament lesion) osteoarthritis (OA) who received primary KA in the period from 2011 and 2 years earlier to data-extraction date. Patients will be identified from the DKR. Patients are followed for 2 years, until first revision, death or migration, whichever comes first.
You may qualify if:
- Primary knee arthroplasty due to osteoarthritis
You may not qualify if:
- Primary knee arthroplasty due to traumatic osteoarthritis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orthopaedic department, Bispebjerg Hospital
Copenhagen, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Søren Overgaard, MD,DMSc,Prof
Department of orthopedic surgery, Bispebjerg University Hospital, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PhD Fellow
Study Record Dates
First Submitted
September 7, 2023
First Posted
May 30, 2024
Study Start
June 1, 2024
Primary Completion
December 2, 2024
Study Completion
February 1, 2025
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share